Notably, genetic polymorphisms in detoxification enzymes such as glutathione S-transferases (GSTs) and NAD(P)H: quinone oxidoreductase 1 (NQO1) have been investigated for their potential role in modulating individual risk for various malignancies and bone marrow failure syndromes [8-10]. The gene discussed is HPGDS; the disease is bone marrow failure syndrome.